Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries - Business Wire

Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries Business WireDr Reddy's enters voluntary licensing deal with Gilead for long-acting HIV drug The Economic TimesDr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug Business StandardDr Reddy's Licenses Gilead's HIV Drug Lenacapavir RediffmailElation and dismay over Gilead’s HIV drug Down To Earth Magazine